港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

维昇药业-B

27.900

+0.1200.43%

成交量：1.73万

成交额：46.25万

市值：31.81亿

市盈率：-14.34

高：28.000

开：27.780

低：26.580

收：27.780

52周最高：54.000

52周最低：24.000

股本：1.14亿

香港流通股本：1.14亿

量比：0.56

换手率：0.02%

股息：- -

股息率：- -

每股收益(LYR):-1.946

净资产收益率：-57.66%

总资产收益率：-29.52%

市净率：3.24

市盈率(LYR):-14.34

市销率: 3296.70

数据加载中...

总览公司新闻资讯公告

维升药业-B盘中异动大幅拉升5.82%

每日卖空追踪 | 维升药业-B 11月27日卖空量成交700股，卖空比例为1.04%

维升药业-B盘中异动大幅上涨5.88%报30.960港元

每日卖空追踪 | 维升药业-B 11月25日卖空量成交300股，卖空比例为2.48%

每日卖空追踪 | 维升药业-B 11月21日卖空量成交1000股，卖空比例为5.38%

安科生物：隆培促生长素审评已正常，此前沟通致暂停

每日卖空追踪 | 维升药业-B 11月20日卖空量成交200股，卖空比例为0.71%

维升药业-B盘中异动早盘股价大跌6.38%

决胜港股升浪·牛启东方2026——第十届智通财经资本市场年会邀您共赴资本盛宴

每日卖空追踪 | 维升药业-B 11月17日卖空量成交100股，卖空比例为0.18%

每日卖空追踪 | 维升药业-B 11月14日卖空量成交100股，卖空比例为0.22%

维升药业尾盘涨超4%公司在进博会达成多项合作携两款全球创新药物登场亮相

维升药业-B盘中异动早盘股价大跌5.02%

打破“进口依赖”，中国医药企业创新速度提升

中国新闻网

直通进博会 | 进博首秀即双签约！维升药业携手东富龙、临港新片区共筑生物医药生态

维升药业进博首秀：“全球创新、中国加速”战略持续落地

维升药业-B(02561.HK)涨超4%

每日经济新闻

港股异动 | 维升药业-B(02561)涨超4% 帕罗培特立帕肽近期在博鳌完成首例处方

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02561/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02561","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02561\",,,,,undefined,":{"symbol":"02561","market":"HK","secType":"STK","nameCN":"维昇药业-B","latestPrice":27.9,"timestamp":1776326892005,"preClose":27.78,"halted":0,"volume":17300,"delay":0,"changeRate":0.004319654427645696,"floatShares":113999999,"shares":113999999,"eps":-1.946273,"marketStatus":"未开盘","change":0.12,"latestTime":"04-16 16:08:12","open":27.78,"high":28,"low":26.58,"amount":462472,"amplitude":0.051116,"askPrice":27.9,"askSize":300,"bidPrice":26.56,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-2.452961,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776389400000},"marketStatusCode":0,"adr":0,"listingDate":1742486400000,"exchange":"SEHK","adjPreClose":27.78,"openAndCloseTimeList":[[1776303000000,1776312000000],[1776315600000,1776326400000]],"volumeRatio":0.5566280577026281,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02561\",,,,,undefined,":{"symbol":"02561","floatShares":113999999,"roa":"-29.52%","roe":"-57.66%","lyrEps":-1.946273,"volumeRatio":0.5566280577026281,"shares":113999999,"dividePrice":0,"high":28,"amplitude":0.051116,"preClose":27.78,"low":26.58,"week52Low":24,"pbRate":"3.24","psRate":"3296.70","week52High":54,"institutionHeld":0,"latestPrice":27.9,"committee":0.538462,"eps":-1.946273,"divideRate":0,"volume":17300,"delay":0,"ttmEps":-2.452961,"open":27.78,"prevYearClose":32.8,"prevWeekClose":25.6,"prevMonthClose":25.8,"prevQuarterClose":25.8,"fiveDayClose":25.5,"twentyDayClose":30.74,"sixtyDayClose":34.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02561\",params:#limit:5,,,undefined,":[{"date":"2026-03-12","symbol":"02561","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773279000000,"name":null,"time":"","dateTimestamp":1773244800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02561\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02561\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1746288000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02561\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02561","date":"2026-04-15","current":-11.374009,"percent":0.940945,"low":-30.760225,"twenty":-27.151956,"median":-18.349759,"eighty":-14.38641,"high":-10.551094,"avg":-20.39749,"sd":6.128986,"marketCap":2917493491},"quantilePoints":[{"date":"2025-04-03","current":-21.475965,"twenty":-22.637245,"median":-22.569747,"eighty":-22.098421,"marketCap":5724824916},{"date":"2025-04-11","current":-18.134639,"twenty":-22.558476,"median":-18.349759,"eighty":-18.045823,"marketCap":4802017317},{"date":"2025-04-17","current":-25.787715,"twenty":-25.955056,"median":-22.513392,"eighty":-18.141011,"marketCap":4682394110},{"date":"2025-04-25","current":-29.965674,"twenty":-27.695216,"median":-22.653961,"eighty":-18.190408,"marketCap":5445704099},{"date":"2025-05-02","current":-28.244363,"twenty":-27.861811,"median":-26.066617,"eighty":-18.349759,"marketCap":5143797909},{"date":"2025-05-09","current":-27.581562,"twenty":-28.248468,"median":-27.028836,"eighty":-20.850724,"marketCap":5058352761},{"date":"2025-05-16","current":-27.481285,"twenty":-28.307048,"median":-27.470681,"eighty":-22.305907,"marketCap":5081138134},{"date":"2025-05-23","current":-29.180898,"twenty":-28.483617,"median":-27.481285,"eighty":-22.603559,"marketCap":5411526040},{"date":"2025-05-30","current":-27.585218,"twenty":-28.483617,"median":-27.495492,"eighty":-22.648389,"marketCap":5138101566},{"date":"2025-06-06","current":-26.147365,"twenty":-28.307048,"median":-27.481285,"eighty":-24.987287,"marketCap":5212154028},{"date":"2025-06-13","current":-28.707887,"twenty":-28.307048,"median":-27.486097,"eighty":-25.744296,"marketCap":5724824916},{"date":"2025-06-20","current":-27.87701,"twenty":-28.483617,"median":-27.500076,"eighty":-26.010837,"marketCap":5548238276},{"date":"2025-06-27","current":-26.600431,"twenty":-28.46744,"median":-27.491566,"eighty":-26.131215,"marketCap":5308991862},{"date":"2025-07-04","current":-25.999842,"twenty":-28.345085,"median":-27.470681,"eighty":-26.039907,"marketCap":5189368655},{"date":"2025-07-11","current":-25.483255,"twenty":-28.252573,"median":-27.442177,"eighty":-25.700877,"marketCap":5081138134},{"date":"2025-07-18","current":-27.275886,"twenty":-28.168194,"median":-27.211053,"eighty":-25.700877,"marketCap":5434311412},{"date":"2025-07-25","current":-27.917728,"twenty":-28.10544,"median":-27.177054,"eighty":-25.808828,"marketCap":5582416336},{"date":"2025-08-01","current":-26.858726,"twenty":-28.252573,"median":-27.236899,"eighty":-25.835301,"marketCap":5337473578},{"date":"2025-08-08","current":-26.45431,"twenty":-28.168194,"median":-27.174901,"eighty":-25.937332,"marketCap":5270256728},{"date":"2025-08-15","current":-27.513449,"twenty":-28.142473,"median":-27.236899,"eighty":-26.012565,"marketCap":5473046546},{"date":"2025-08-22","current":-26.703746,"twenty":-28.118557,"median":-27.177054,"eighty":-26.021282,"marketCap":5295320638},{"date":"2025-08-29","current":-26.119434,"twenty":-28.10544,"median":-27.144467,"eighty":-26.021282,"marketCap":5204179147},{"date":"2025-09-05","current":-23.791598,"twenty":-28.093765,"median":-27.114576,"eighty":-25.835301,"marketCap":4735670561},{"date":"2025-09-12","current":-23.381705,"twenty":-28.083375,"median":-27.05699,"eighty":-25.694259,"marketCap":4662460107},{"date":"2025-09-19","current":-23.051901,"twenty":-28.060478,"median":-27.021811,"eighty":-25.478949,"marketCap":4593433106},{"date":"2025-09-26","current":-21.933119,"twenty":-28.003961,"median":-26.881441,"eighty":-23.835003,"marketCap":4359159651},{"date":"2025-10-03","current":-19.179371,"twenty":-27.951558,"median":-26.814509,"eighty":-23.612343,"marketCap":4545323379},{"date":"2025-10-10","current":-18.42629,"twenty":-27.909584,"median":-26.722604,"eighty":-23.450061,"marketCap":4360487033},{"date":"2025-10-17","current":-18.280755,"twenty":-27.87397,"median":-26.671617,"eighty":-23.093007,"marketCap":4322679342},{"date":"2025-10-24","current":-17.856771,"twenty":-27.855424,"median":-26.557884,"eighty":-22.535934,"marketCap":4223959260},{"date":"2025-10-31","current":-16.854881,"twenty":-27.829876,"median":-26.452186,"eighty":-21.933119,"marketCap":3992912259},{"date":"2025-11-07","current":-16.17341,"twenty":-27.822718,"median":-26.363703,"eighty":-19.806882,"marketCap":3829078931},{"date":"2025-11-14","current":-14.606062,"twenty":-27.750423,"median":-26.249352,"eighty":-18.799844,"marketCap":3467805439},{"date":"2025-11-21","current":-13.329485,"twenty":-27.732081,"median":-26.119434,"eighty":-18.28655,"marketCap":3163243483},{"date":"2025-11-28","current":-13.563448,"twenty":-27.641863,"median":-26.021242,"eighty":-18.15057,"marketCap":3230457156},{"date":"2025-12-05","current":-15.697088,"twenty":-27.585218,"median":-25.856964,"eighty":-18.047863,"marketCap":3745061840},{"date":"2025-12-12","current":-16.915932,"twenty":-27.581562,"median":-25.811068,"eighty":-17.856771,"marketCap":4043322514},{"date":"2025-12-19","current":-15.561133,"twenty":-27.572592,"median":-25.748021,"eighty":-17.298197,"marketCap":3728258422},{"date":"2025-12-24","current":-15.871137,"twenty":-27.537106,"median":-25.592118,"eighty":-16.909424,"marketCap":3814375940},{"date":"2026-01-02","current":-14.633696,"twenty":-27.513319,"median":-25.499704,"eighty":-16.617104,"marketCap":3530818257},{"date":"2026-01-09","current":-14.6234,"twenty":-27.507904,"median":-25.36554,"eighty":-16.251482,"marketCap":3537119539},{"date":"2026-01-16","current":-14.627967,"twenty":-27.496935,"median":-23.827768,"eighty":-15.946573,"marketCap":3549722103},{"date":"2026-01-23","current":-16.340142,"twenty":-27.491697,"median":-23.637534,"eighty":-15.766708,"marketCap":3961405850},{"date":"2026-01-30","current":-14.661628,"twenty":-27.487059,"median":-23.520828,"eighty":-15.582389,"marketCap":3570726376},{"date":"2026-02-06","current":-14.624534,"twenty":-27.472802,"median":-23.381705,"eighty":-15.41764,"marketCap":3570726376},{"date":"2026-02-13","current":-14.275853,"twenty":-27.453945,"median":-23.154666,"eighty":-15.203628,"marketCap":3505613130},{"date":"2026-02-20","current":-14.390669,"twenty":-27.447813,"median":-22.932516,"eighty":-15.172676,"marketCap":3528717830},{"date":"2026-02-27","current":-13.887168,"twenty":-27.442691,"median":-22.626101,"eighty":-15.007296,"marketCap":3442600311},{"date":"2026-03-06","current":-13.692525,"twenty":-27.436603,"median":-22.183333,"eighty":-14.876498,"marketCap":3366984929},{"date":"2026-03-13","current":-13.213121,"twenty":-27.307751,"median":-21.922595,"eighty":-14.759688,"marketCap":3264063993},{"date":"2026-03-20","current":-11.103996,"twenty":-27.213507,"median":-20.641424,"eighty":-14.63255,"marketCap":2732655891},{"date":"2026-03-27","current":-11.448917,"twenty":-27.181226,"median":-19.179371,"eighty":-14.605,"marketCap":2810371700},{"date":"2026-04-02","current":-10.551094,"twenty":-27.175762,"median":-18.799844,"eighty":-14.511725,"marketCap":2602429399},{"date":"2026-04-10","current":-10.816815,"twenty":-27.169165,"median":-18.593258,"eighty":-14.452927,"marketCap":2688546918},{"date":"2026-04-15","current":-11.712446,"twenty":-27.151956,"median":-18.349759,"eighty":-14.38641,"marketCap":2917493491}],"updateTime":1776379859744},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02561\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586270978","title":"维升药业-B盘中异动 大幅拉升5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586270978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586270978?lang=zh_cn&edition=fundamental","pubTime":"2025-11-28 10:28","pubTimestamp":1764296913,"startTime":"0","endTime":"0","summary":"2025年11月28日早盘10时28分，维升药业-B股票出现异动，股价快速上涨5.82%。截至发稿，该股报32.020港元/股，成交量5400股，换手率0.00%，振幅6.81%。维升药业-B股票所在的生物技术行业中，整体跌幅为0.82%。其相关个股中，华康生物医学、拨康视云-B、维升药业-B涨幅较大，振幅较大的相关个股有拨康视云-B、派格生物医药-B、科笛-B，振幅分别为14.74%、11.43%、7.75%。维升药业-B公司简介：维升药业是一家主要从事开发并商业化颠覆式内分泌疗法的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128102833a4bf4a54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128102833a4bf4a54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586908270","title":"每日卖空追踪 | 维升药业-B 11月27日卖空量成交700股，卖空比例为1.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586908270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586908270?lang=zh_cn&edition=fundamental","pubTime":"2025-11-27 16:30","pubTimestamp":1764232228,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月27日，涨3.49%，卖空量成交700股，较上一交易日增加133.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511271637169782643f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511271637169782643f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586218827","title":"维升药业-B盘中异动 大幅上涨5.88%报30.960港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586218827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586218827?lang=zh_cn&edition=fundamental","pubTime":"2025-11-27 09:34","pubTimestamp":1764207293,"startTime":"0","endTime":"0","summary":"2025年11月27日早盘09时34分，维升药业-B股票出现异动，股价快速上涨5.88%。截至发稿，该股报30.960港元/股，成交量1000股，换手率0.00%，振幅2.94%。资金方面，该股资金流入1.224万港元，流出9116港元。维升药业-B股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，维升药业-B、博安生物、派格生物医药-B涨幅较大，振幅较大的相关个股有派格生物医药-B、药明巨诺-B、拨康视云-B，振幅分别为8.33%、7.17%、6.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127093453a71404d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127093453a71404d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586840179","title":"每日卖空追踪 | 维升药业-B 11月25日卖空量成交300股，卖空比例为2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586840179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586840179?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 16:30","pubTimestamp":1764059430,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月25日，股价较前一交易日持平，卖空量成交300股，较上一交易日减少40%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112516343495192e3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112516343495192e3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585758161","title":"每日卖空追踪 | 维升药业-B 11月21日卖空量成交1000股，卖空比例为5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585758161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585758161?lang=zh_cn&edition=fundamental","pubTime":"2025-11-21 16:30","pubTimestamp":1763713831,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月21日，跌4.56%，卖空量成交1000股，较上一交易日减少41.18%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163432a4b128f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163432a4b128f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585150040","title":"安科生物：隆培促生长素审评已正常，此前沟通致暂停","url":"https://stock-news.laohu8.com/highlight/detail?id=2585150040","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585150040?lang=zh_cn&edition=fundamental","pubTime":"2025-11-20 17:04","pubTimestamp":1763629440,"startTime":"0","endTime":"0","summary":"投资者提问：隆培促生长素的进展贵司有没有跟进？据我了解，隆培促生长素处于审批暂停状态，需要提交资料，合规方面无法通过，2025年已经拿不到批号了。贵司对维升药业的投资是否包含相关上市承诺？董秘回答(安科生物SZ300009)：您好，之前维升药业与药审中心就生产细节进行沟通，所以审评处于暂停状态，目前相关沟通已经结束，审评开关已经打开，隆培促生长素处于正常审评中。谢谢您的关注。查看更多董秘问答>>免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不保证数据的准确性，内容仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511201806439510612f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511201806439510612f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585168838","title":"每日卖空追踪 | 维升药业-B 11月20日卖空量成交200股，卖空比例为0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585168838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585168838?lang=zh_cn&edition=fundamental","pubTime":"2025-11-20 16:30","pubTimestamp":1763627430,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月20日，跌1.31%，卖空量成交200股，较上一交易日减少92%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112016362895103be1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112016362895103be1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584925085","title":"维升药业-B盘中异动 早盘股价大跌6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584925085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584925085?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 09:51","pubTimestamp":1763517095,"startTime":"0","endTime":"0","summary":"2025年11月19日早盘09时51分，维升药业-B股票出现波动，股价急速跳水6.38%。截至发稿，该股报32.000港元/股，成交量8600股，换手率0.01%，振幅2.93%。维升药业-B股票所在的生物技术行业中，整体跌幅为0.27%。维升药业-B公司简介：维升药业是一家主要从事开发并商业化颠覆式内分泌疗法的投资控股公司。隆培促生长素用于治疗3至17岁儿童生长激素缺乏症患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119095135950d5c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119095135950d5c7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584023605","title":"决胜港股升浪·牛启东方2026——第十届智通财经资本市场年会邀您共赴资本盛宴","url":"https://stock-news.laohu8.com/highlight/detail?id=2584023605","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584023605?lang=zh_cn&edition=fundamental","pubTime":"2025-11-18 08:53","pubTimestamp":1763427196,"startTime":"0","endTime":"0","summary":"由港美股第一资讯平台智通财经与中资海外私募基金一站式服务平台新智基金网联合主办，“冬日暖阳” 独家承办，S&P Global Market Intelligence、CITIZEN支持的“第十届智通财经资本市场年会”将于2025年12月3-5日联动深圳与香港两地举行。本届年会以\"决胜港股升浪·牛启东方2026\"为主题，设置六大核心议程，汇聚全球资本力量，共探宽松周期尾声的领涨赛道与中国资产长期增长潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00604","06682","02561","06609","01333","03658","00290","00305","06660","09996","02142","00363","00826","01318","02420","00552","02256","09911","01164","00196","00855","02431","02453","06996","02171","09878","00867","02096","00861","00382","02670","00302","06608","00699","02105","01167","02627","02587","01228","02157","02177","02279","02488","00003","02509","02268","02511","09959","09678","02167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584671821","title":"每日卖空追踪 | 维升药业-B 11月17日卖空量成交100股，卖空比例为0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584671821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584671821?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:30","pubTimestamp":1763368229,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月17日，涨1.15%，卖空量成交100股，较上一交易日持平更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163437a4a72e23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163437a4a72e23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583635659","title":"每日卖空追踪 | 维升药业-B 11月14日卖空量成交100股，卖空比例为0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583635659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583635659?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 16:30","pubTimestamp":1763109032,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月14日，跌4.18%，卖空量成交100股，较上一交易日增加100%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114164018a4a11b3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114164018a4a11b3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583915625","title":"维升药业尾盘涨超4%公司在进博会达成多项合作携两款全球创新药物登场亮相","url":"https://stock-news.laohu8.com/highlight/detail?id=2583915625","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583915625?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 15:15","pubTimestamp":1763018100,"startTime":"0","endTime":"0","summary":"港股维升药业-B(02561)尾盘涨超4%，截至发稿涨4.05%，报34.98港元，成交额96.64万港元。11月6日第八届进博会期间，维升药业达成多项合作，与东富龙达成双腔冻干制剂技术战略合作，还与临港新片区管委会等签署产业协同协议，推动“全球创新、中国加速”战略进一步落地。此外，维升药业今年首次以参展商身份亮相进博会，携两款全球创新药物登场，包括全球首个且唯一用于治疗成人慢性甲状旁腺功能减退症（HP）的激素替代治疗药物帕罗培特立帕肽，以及致力于成为“潜在同类最佳”的隆培生长激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511131526239501affd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511131526239501affd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06978","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582312262","title":"维升药业-B盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582312262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582312262?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 10:27","pubTimestamp":1762828061,"startTime":"0","endTime":"0","summary":"2025年11月11日早盘10时27分，维升药业-B股票出现异动，股价急速下挫5.02%。资金方面，该股资金流入18.1122万港元，流出16.5002万港元。维升药业-B股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，旺山旺水-B、嘉和生物-B、华康生物医学涨幅较大，振幅较大的相关个股有旺山旺水-B、嘉和生物-B、维升药业-B，振幅分别为14.47%、12.67%、7.64%。维升药业-B公司简介：维升药业是一家主要从事开发并商业化颠覆式内分泌疗法的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111102741a49898d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111102741a49898d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582804221","title":"打破“进口依赖”，中国医药企业创新速度提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2582804221","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582804221?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 00:05","pubTimestamp":1762790700,"startTime":"0","endTime":"0","summary":"在这场全球经贸盛会上，中国医药健康产业呈现出前所未有的创新活力：从AI赋能的智慧医疗，到全球新药加速落地，一系列变革正在推动行业从“追赶者”走向“共创者”。在肿瘤治疗领域，复星医药同样带来多项创新突破。同时，复星凯瑞的第二款CAR-T产品也已提交上市申请。以“全球重要采购方”的角色，向世界传递出中国对创新药械的稳定需求和扩大采购的明确意愿。正如复星国际董事长郭广昌所言，中国的医药创新越来越获得全世界的认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111100081394fbb7d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111100081394fbb7d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581001197","title":"直通进博会 | 进博首秀即双签约！维升药业携手东富龙、临港新片区共筑生物医药生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2581001197","media":"新华财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581001197?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 11:19","pubTimestamp":1762485572,"startTime":"0","endTime":"0","summary":"深耕临港产业生态 夯实本土发展根基值得关注的是，维升药业是临港新片区洋山特殊综合保税区重点引进的一家专注于内分泌相关治疗领域的创新型生物医药企业，治疗范围涵盖成人内分泌、儿童内分泌及内分泌罕见病。此次维升药业与临港新片区管委会、临港集团物贸平台的签约，则进一步深化了公司与临港的产业协同关系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110711195997598c36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110711195997598c36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581001166","title":"维升药业进博首秀：“全球创新、中国加速”战略持续落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2581001166","media":"环球网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581001166?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 09:32","pubTimestamp":1762479128,"startTime":"0","endTime":"0","summary":"11月5日，内分泌领域创新药企维升药业首次以参展商身份亮相第八届中国国际进口博览会，携两款全球创新药物重磅登场——“全球首创”药物帕罗培特立帕肽凭借其卓越创新性入选本届“进博好物”；另一致力于成为“潜在同类最佳”药物隆培生长激素也同步首展，充分彰显维升药业“全球创新、中国加速”的战略实践。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107093448a6e73895&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107093448a6e73895&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580479259","title":"维升药业-B(02561.HK)涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580479259","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580479259?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 10:33","pubTimestamp":1762137194,"startTime":"0","endTime":"0","summary":"维升药业-B(02561.HK)涨超4%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511033553273518.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511033553273518.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580259870","title":"港股异动 | 维升药业-B(02561)涨超4% 帕罗培特立帕肽近期在博鳌完成首例处方","url":"https://stock-news.laohu8.com/highlight/detail?id=2580259870","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580259870?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 10:22","pubTimestamp":1762136549,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，维升药业-B涨超4%，截至发稿，涨4.68%，报39.8港元。据悉，该药目前已在欧美主要国家获批上市，是全球首个且唯一一款甲旁减激素替代治疗药物。维升药业首席执行官兼执行董事卢安邦表示，帕罗培特立帕肽在博鳌完成首例处方，是维升药业致力于内分泌领域创新的重要一步。公司将继续与各方紧密合作，加速推动该药国内全面获批，并持续深耕内分泌创新疗法。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"628fecc566bce7ba17e7dea241a462ec","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":58,"code":"91000000","status":"200"}]}}